![Joseph Turner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph Turner
Direktor/Vorstandsmitglied bei Swarthmore College
Vermögen: 36 048 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Joseph Turner
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 84 | |
Swarthmore College
40
| College/University | Other Consumer Services | 40 |
Subsidiary | Pharmaceuticals: Major | 33 | |
Public Company | Pharmaceuticals: Major | 25 | |
Subsidiary | Pharmaceuticals: Major | 21 | |
Public Company | Pharmaceuticals: Major | 12 | |
Gilead Colorado, Inc.
![]() Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
SGX Pharmaceuticals, Inc.
![]() SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Rainier Therapeutics, Inc.
![]() Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA.
6
| Subsidiary | Biotechnology | 6 |
Extinct | Pharmaceuticals: Major | 5 | |
Cortech, Inc.
3
| Extinct | Biotechnology | 3 |
QLT, Inc.
![]() QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.
3
| Extinct | Miscellaneous Commercial Services | 3 |
Allos Therapeutics, Inc.
![]() Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Centaur Pharmaceuticals, Inc.
1
| Extinct | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Joseph Turner
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Administrative Officer General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director of Finance/CFO Founder Director/Board Member | |
UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman Founder Director of Finance/CFO General Counsel | |
Stanford University | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Masters Business Admin Corporate Officer/Principal | |
University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal General Counsel | |
ALLERGAN, INC. | Pharmaceuticals: Major | President Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
AFFYMAX, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Yale University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
ALLERGAN PLC | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
ARCH Venture Partners LLC
![]() ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
Allergan GI Corp.
![]() Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member Director/Board Member President | |
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of Michigan | College/University | Masters Business Admin Masters Business Admin Corporate Officer/Principal | |
The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Kellogg School of Management | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
Swarthmore College Endowment | Director/Board Member Director/Board Member Corporate Officer/Principal | ||
ANAPTYSBIO, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Michigan State University | College/University | Masters Business Admin Undergraduate Degree | |
SurroMed, Inc.
![]() SurroMed, Inc. Miscellaneous Commercial ServicesCommercial Services SurroMed, Inc. provides pharmaceutical research. It focuses on discovering & applying biomarkers to improve the drug discovery and development process and enable the precise diagnosis and personalized treatment of disease. The company's research process yields biological markers and information that enable accelerated, cost-efficient discovery and development of new therapeutic products, as well as development of diagnostic tests for early disease detection, disease staging, patient stratification, guiding and monitoring therapy. SurroMed was founded in 1997 and is located in Menlo Park, CA. | Miscellaneous Commercial Services | Founder Chief Executive Officer | |
Sanifit Therapeutics SA
![]() Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
Maxygen, Inc.
![]() Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
PFENEX INC. | Biotechnology | Chairman Director/Board Member | |
PHARMACYCLICS, INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
CERUS CORPORATION | Medical Specialties | Director/Board Member Chairman | |
FORD MOTOR COMPANY | Motor Vehicles | Director/Board Member Corporate Officer/Principal | |
Somatogen, Inc.
![]() Somatogen, Inc. BiotechnologyHealth Technology Somatogen, Inc. develops specialty oxygen therapeutics. It is engaged in the research, clinical development and commercialization of genetically engineered recombinant human hemoglobin-based products. The company is located in Boulder, CO. | Biotechnology | Founder Corporate Officer/Principal | |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
United Way of Central Indiana, Inc.
![]() United Way of Central Indiana, Inc. Services to the Health IndustryHealth Services United Way of Central Indiana, Inc. provides social services. The firm specializes in health, financial stability, community impact, live united, basic needs and connecting resources. The company was founded in 1986 and is headquartered in Indianapolis, IN. | Services to the Health Industry | Director/Board Member Director/Board Member | |
Princeton University | College/University | Undergraduate Degree Corporate Officer/Principal | |
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Cirius Therapeutics, Inc.
![]() Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | Biotechnology | Chairman Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
University of California, Berkeley Foundation
![]() University of California, Berkeley Foundation Investment Trusts/Mutual FundsMiscellaneous University of California, Berkeley Foundation engages in the provision of philanthropic services.It offers social services and supports the advancement of higher education by securing private financial support. The company was founded by Phoebe Apperson Hearst, Jane Sather, Charles Franklin Doe in 1868 and is headquartered in Berkeley, CA. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Corvidia Therapeutics, Inc.
![]() Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
GENMAB A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
Altos Labs, Inc.
![]() Altos Labs, Inc. BiotechnologyHealth Technology Altos Labs is a biotechnology company that focuses on cellular rejuvenation programming to restore cell health and resilience. The company is based in Redwood City, CA. The company's goal is to reverse disease and transform medicine. Altos Labs was founded by Rick Klausner and Hans Edgar Bishop. The CEO is Hal V. Barron. | Biotechnology | Director/Board Member Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 46 |
Irland | 3 |
Vereinigtes Königreich | 2 |
Spanien | 2 |
Dänemark | 2 |
Sektoral
Health Technology | 33 |
Consumer Services | 11 |
Commercial Services | 4 |
Finance | 2 |
Consumer Durables | 2 |
Operativ
Director/Board Member | 774 |
Corporate Officer/Principal | 214 |
Independent Dir/Board Member | 203 |
Chairman | 125 |
President | 90 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Robert Nelsen | 80 |
Daniel Bradbury | 45 |
Jonathan Silverstein | 42 |
Stephen Hoffman | 33 |
Ambrose Bailey | 32 |
Michael Grey | 32 |
Deepa Pakianathan | 32 |
Camille Samuels | 30 |
David Kabakoff | 30 |
Dennis Fenton | 28 |
Karen N. Horn | 28 |
Rolf K. Hoffmann | 27 |
Corey Mulloy | 27 |
Amit Munshi | 27 |
J. Read | 27 |
- Börse
- Insiders
- Joseph Turner
- Unternehmensverbindungen